Cochrane Abstracts
Nicotine for Alzheimer's disease: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Nicotine for Alzheimer's Disease: Cochrane Systematic Review." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431124/all/Nicotine_for_Alzheimer&apos.
Nicotine for Alzheimer's disease: Cochrane systematic review. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431124/all/Nicotine_for_Alzheimer&apos. Accessed February 12, 2026.
Nicotine for Alzheimer's disease: Cochrane systematic review. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431124/all/Nicotine_for_Alzheimer&apos
Nicotine for Alzheimer's Disease: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 February 12]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431124/all/Nicotine_for_Alzheimer&apos.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Nicotine for Alzheimer's disease: Cochrane systematic review
ID - 431124
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431124/all/Nicotine_for_Alzheimer&apos
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
